CEO Shawn Nelson highlighted that fiscal 2025 featured the company’s most prolific year of new product launches, including the Reclining Seat and PillowSac Accent Chair. He stated, "We codified our ...

Boston Scientific Corp.’s Farapulse pulsed field ablation system racked up more than $1 billion in revenue in its first year; its Watchman left atrial appendage occluder holds more than 90% of the ...

CEO Reshma Kewalramani highlighted a strong start to 2025 with $2.77 billion in revenue for Q1, marking a 3% increase over Q1 2024. She emphasized the successful launches of ALYFTREK, JOURNAVX, and ...

Successful product launches rely on more than just scientific excellence or commercial savvy—they demand seamless collaboration between medical and commercial teams. These functions, while distinct, ...

CEO Amanda Baldwin opened the call highlighting that "third quarter results...exceeded our expectations," with improvement in sell-through trends coinciding with the Hair Mask launch and the company's ...

The MarketWatch News Department was not involved in the creation of this content. The newly FDA-cleared uMR(R) Ultra and the uOmniscan(TM) are the first major announcements leading into the AHRA ...